Table 2.
State | Inactivator | Donor NBO (i) | Acceptor NBO (j) | E2 (kcal/mol) | Total (kcal/mol) |
---|---|---|---|---|---|
| |||||
Reactants | CPP-115 | σ(Cα-H) | π*(C4’-N)(2) | 3.17 | 6.20 |
σ(Cα-H) | π*(Cβ2-Cγ2)(2) | 3.03 | |||
| |||||
OV329 | σ(Cα-H) | π*(C4’-N)(1) | 1.00 | 7.87 | |
σ(Cα-H) | π*(C4’-N)(2) | 2.90 | |||
σ(Cα-H) | π*(Cβ2-Cγ2)(2) | 1.92 | |||
σ(Cα-H) | π* (Cβ1-Cγ1)(2) | 2.05 | |||
| |||||
TS | CPP-115 | LP(Cα) | π*(C4’-N)(2) | 59.70 | 90.11 |
LP(Cα) | π*(Cβ2-Cγ2)(2) | 30.41 | |||
| |||||
OV329 | LP(Cα) | π*(C4’-N)(2) | 44.61 | 92.00 | |
LP(Cα) | π*(Cβ2-Cγ2)(2) | 26.55 | |||
LP(Cα) | π* (Cβ1-Cγ1)(2) | 2084 |